Tissue expression
Cell line expression
Protein structure
RFX5
Regulatory factor X5A lack of MHC-II expression results in a severe immunodeficiency syndrome called MHC-II deficiency, or the bare lymphocyte syndrome (BLS; MIM 209920). At least 4 complementation groups have been identified in B-cell lines established from patients with BLS. The molecular defects in complementation groups B, C, and D all lead to a deficiency in RFX, a nuclear protein complex that binds to the X box of MHC-II promoters. The lack of RFX binding activity in complementation group C results from mutations in the RFX5 gene encoding the 75-kD subunit of RFX (Steimle et al., 1995). RFX5 is the fifth member of the growing family of DNA-binding proteins sharing a novel and highly characteristic DNA-binding domain called the RFX motif. Multiple alternatively spliced transcript variants have been found but the full-length natures of only two have been determined. [provided by RefSeq, Jul 2008]
Top validated antibodies |
|||||
Novus Biologicals | NB100-195 | 2 references | Polyclonal |
WB
IP
IHC
|
|
Invitrogen Antibodies | PA1-32133 | 1 references | Polyclonal |
WB
EL
GS
ChIP
OA
|
|
antibodies-online | ABIN151448 | 1 references | Polyclonal |
WB
IP
IHC
|
|
GeneTex | GTX27542 | Polyclonal |
WB
EL
GS
ChIP |
||
Proteintech Group | 12137-1-AP | 2 references | Polyclonal |
WB
EL |
All Antibodies
Filters
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider